Physician profile
James Stringham
NPI 1538182449
$824.42
in general payments reported to CMS, 2019-2025
18 companies · $16.68 in 2025
The $16.68 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.85 · 2020: $30.93 · 2021: $50.33 · 2022: $245 · 2023: $270 · 2024: $196 · 2025: $16.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $483.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $265.94 | 2022-2023 | |
| Intuitive Surgical, INC. | $107.65 | 2023-2024 | |
| Edwards Lifesciences Corporation | $67.56 | 2019-2023 | Mitris Resilia Mitral Valve |
| Medtronic, INC. | $49.73 | 2022-2023 | Endurant Iis |
| Depuy Synthes Sales INC. | $38.59 | 2022 | |
| Pfizer INC. | $36.88 | 2021-2022 | |
| Inspire Medical Systems, INC. | $33.95 | 2023-2024 | Inspire |
| Sanara Medtech INC. | $32.13 | 2024 | Celleraterx |
| Medtronic Vascular, INC. | $30.93 | 2020 | |
| Janssen Pharmaceuticals, INC | $28.83 | 2023 | Xarelto |
| Grifols USA, LLC | $20.88 | 2024 | Prolastin-C Liquid |
| Active Medical, LLC | $19.58 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $16.90 | 2023 | Camzyos |
| Averitas Pharma INC. | $16.68 | 2025 | Qutenza |
| Bolton Medical INC | $14.89 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.80 | 2023 | Verquvo |
| Philips North America LLC | $14.73 | 2023 | |
| Atricure, INC. | $13.77 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Stringham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.